Correlation of a unique 220-kDa protein with vitamin D sensitivity in glioma cells.
We have investigated the antitumor and apoptotic effects of 1, 25-dihydroxyvitamin D(3) (VD(3)) in glioma cell lines and in primary cultures derived from surgical specimens from patients. Our results showed that certain glioma cells underwent apoptosis, whereas others were resistant. In an attempt to search for parameters that dictate VD(3) sensitivity, we discovered a unique 220-kDa protein in glioma cells that were sensitive to VD(3). This protein was not a classical vitamin D receptor (VDR), but was recognized by two different anti-VDR monoclonal antibodies. Furthermore, the level of the 220-kDa protein was inversely correlated with the IC(50) of VD(3) in these glioma cells. This 220-kDa protein was also present in frozen brain tumor samples, and the level of expression appeared to correlate with their corresponding primary cultures. Thus, our findings suggest that this 220-kDa protein may play an important role in determining VD(3) sensitivity in malignant glioma.
Zou
J
J
Hematology/Oncology Section, Department of Medicine, VA Medical Center, University of Miami School of Medicine, Miami, FL 33125, USA.
Landy
H
H
Feun
L
L
Xu
R
R
Lampidis
T
T
Wu
C J
CJ
Furst
A J
AJ
Savaraj
N
N
D017209:Apoptosis; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D002455:Cell Division / Q000187:drug effects; D053938:DNA Fragmentation / Q000187:drug effects; D005910:Glioma / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D006801:Humans; D014407:Tumor Cells, Cultured; D014807:Vitamin D / Q000494:pharmacology*
D014807:Vitamin D